Smoking Cessation and Lung Cancer Risk in an Asian Population: Findings from the Singapore Chinese Health Study
Overview
Affiliations
Background: Smoking cessation is an important strategy for reducing the harmful effects of tobacco, particularly in the prevention of lung cancer; however, prospective data on the impact of smoking cessation on lung cancer risk in Asian populations are limited.
Methods: We studied a population-based cohort of Chinese men and women aged 45-74 years--participants of the Singapore Chinese Health Study. Information on smoking, lifestyle and dietary habits was collected at the time of recruitment in 1993-1998; and smoking status was assessed again at a second interview in 1999-2004 (mean interval 5.8 years). Participants were followed up to 31 December 2007, and incident cases of lung cancer were ascertained by linkage with population-wide registries.
Results: Among 45,900 participants, there were 463 incident cases of lung cancer. Relative to current smokers, those who quit smoking subsequent to baseline assessment had a 28% decrease in the risk of lung cancer (adjusted hazard ratio (HR) 0.72; 95% CI (95% confidence interval): 0.53-0.98). The risk was less than half in ex-smokers who had quit before the first interview and maintained their status (HR 0.42; 95% CI: 0.32-0.56).
Conclusions: Reduction in lung cancer incidence with smoking cessation in Asian populations is substantial and can be observed within a few years after quitting.
Tran T, Kim S, Kim S, Park B Cancer Res Treat. 2023; 56(1):18-26.
PMID: 37536711 PMC: 10789971. DOI: 10.4143/crt.2023.341.
Smoking Cessation Interventions for Chinese American Smokers: A Systematic Review and Meta-Analysis.
Lei F, Zheng Y Asian Pac J Cancer Prev. 2023; 24(3):753-768.
PMID: 36974527 PMC: 10334092. DOI: 10.31557/APJCP.2023.24.3.753.
Cai J, Wei Z, Chen M, He L, Wang H, Li M Eur Psychiatry. 2022; 65(1):e28.
PMID: 35431011 PMC: 9158396. DOI: 10.1192/j.eurpsy.2022.18.
Age at first birth and lung cancer: a two-sample Mendelian randomization study.
Peng H, Wu X, Wen Y, Du X, Li C, Liang H Transl Lung Cancer Res. 2021; 10(4):1720-1733.
PMID: 34012788 PMC: 8107761. DOI: 10.21037/tlcr-20-1216.
Chang X, Gurung R, Wang L, Jin A, Li Z, Wang R Commun Biol. 2021; 4(1):519.
PMID: 33941849 PMC: 8093266. DOI: 10.1038/s42003-021-02056-7.